Compumedics Ltd (ASX:CMP) CFO and company secretary David Lawson joins Jonathan Jackson in the Proactive studio to discuss CMP’s strong H1 FY24. The company leaped back to profitability and growth in the half, with sales invoiced and shipped up 38% to $26.4 million for H1 FY24, compared to H1 FY23. Sales orders taken were up 75% at $30.4 million, profits return with EBITDA was $2.2 million for H1 FY24, compared to a $(4.8)million loss for H1 FY23. Revenues for the core business grew 13% to $21.7 million for H1 FY24, compared to $19.2 million for H1 FY23. Lawson discusses the drivers of the turnaround, including with OrionMEG, Somfit and eHealth. Finally, he discusses the forward outlook and what to expect from the company in terms of growth opportunities.
Compumedics moves back to profitability
